Gland Pharma Ltd.

GLAND

₹1781.3

-1.98% (-36.0)

Market Cap

₹29,622 Cr.

P/E

37.48

Key Ratios

Edit Ratio's

Market cap

29,622 Cr

37.48

Prom Holding

51.83 %

ROE (%)

7.63

ROCE (%)

11.50

Div Yield (%)

0.99

Sales

5,801 Cr

OPM (%)

23.94 %

Debt to Equity

0.03

Edit Ratio's

About

Gland Pharma Limited specializes in providing a range of injectable products in therapeutic ar… Read more

Low

1278

52W Range

High

2131

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

8 Yes

Positive for this company

3 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
Capex vs ROCE

Company has made significant capex which might be affecting its roce
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Share price

Share price has decreased over last 10 years more due to earnings
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Distribution Channel

Operational Metrics

Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
US DMF Filings (.)
Source
R&D as a % of Total Sales (%)
Source
API Capacity (Kg/Year)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

Mold-Tek Technologies Ltd.

FAQs on Gland Pharma Ltd. Business

What does Gland Pharma do?

Gland Pharma Limited focuses on providing affordable and high-quality injectables across various therapeutic areas and delivery systems including complex injectables and new delivery systems like pens and cartridges.

Who are the competitors of Gland Pharma?

Gland Pharma major competitors are Caplin Point Lab, Gufic Biosciences, JB Chem & Pharma, Ajanta Pharma, Pfizer, Astrazeneca Pharma I, Eris Lifesciences.
Market Cap of Gland Pharma is ₹29,933 Crs.
While the median market cap of its peers are ₹22,779 Crs.

Is Gland Pharma financially stable compared to its competitors?

Gland Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Gland Pharma is 11.29 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May Aug Nov	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Dec
Investor Presentation	May Aug Nov	Feb Mar Jun Sep Dec	Mar Jun Sep Dec	Mar May Jun Jul Sep Dec	Jan Mar Jun Sep Dec	Dec
Conference Call	Mar Jun Nov	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Gland Pharma Ltd.

Complete Analysis of Gland Pharma - Sadhan

Gland Pharma Analysis - Pure play injectables player - Value Educator

View the discussion on ValuePickr

Corporate Governance Red Flags At Gland Pharma - Beat The Street

The Business Risk Of Gland Pharma According to Aditya Khemka - Incred

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Gland Pharma Ltd.

Gland Pharma Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

8 Yes

3 Neutral

6 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Other Income

Pledge

Promoter Holding

Retail Holding

Revenue Recognition

Price & Performance

ROE

Current vs Historic Valuation

Debt

Sales Growth

Capex vs ROCE

Balance Sheet Strength

Share price

Working Capital

Margin Stability

ROCE Strength

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Distribution Channel

UNLOCK PREMIUM

Operational Metrics

Peer Comparison

Corporate Actions

Suppliers

FAQs on Gland Pharma Ltd. Business

What does Gland Pharma do?

Who are the competitors of Gland Pharma?

Is Gland Pharma financially stable compared to its competitors?

Similar Companies

Company Filing

Discussions & Analysis

SIGN UP FOR FREE